MedTrace Logo

New Biomarkers and Difficult-to-treat Hypertension

NCT03034265 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2017-12-20

No results posted yet for this study

Summary

The purpose of this study is to determine the concentrations and variabilities of urinary exosomal sodium channels and plasma angiotensins in patients with difficult-to-treat arterial hypertension and to investigate their dependency on clinical parameters and sampling conditions.

Conditions

Sponsors & Collaborators

  • University of Zurich

    collaborator OTHER

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Jürgen Bohlender, M.D. · Inselspital, Bern University Hospital, Freiburgstr. 4, 3010 Bern, Switzerland

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03034265 on ClinicalTrials.gov